November 11, 2010 (Atlanta, Georgia) — Modified-release (MR) prednisone is safe and more effective for morning symptoms of chronic rheumatoid arthritis (RA) than immediate-release prednisone or ...

DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- Horizon Pharma, Inc., (NASDAQ: HZNP) announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS ® (prednisone) delayed-release ...

The researchers found that participants in the MR group showed higher ACR20 response rates than did the placebo group (48% versus 29%, P<0.001). Patients in the MR group also displayed a greater ...

THE adrenal steroids have attained wide acceptance as therapeutic agents in the treatment of rheumatoid arthritis. The chemical analogue of cortisone, prednisone, has properties that have made the ...

THE new adrenocortical steroid prednisone 1 was used in the treatment of 33 patients with rheumatoid arthritis. Among 33 patients with rheumatoid arthritis treated with prednisone, the disease was of ...

Share on Pinterest A new study looked at the effects of taking low dose steroids for people with rheumatoid arthritis. rudi suardi/Getty Images New research suggests that low doses of medications like ...

RAYOS approved for key rheumatology indications such as Rheumatoid Arthritis, Polymyalgia Rheumatica, Psoriatic Arthritis and Ankylosing Spondylitis. DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- ...